Management of squamous cell vulvar cancer: A review

被引：18

作者：

Deppe, Gunter ^{[1
,2
]}

Mert, Ismail ^{[1
]}

Winer, Ira S. ^{[1
,2
]}

机构：

[1] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA

[2] Wayne State Univ, Div Gynecol Oncol, Detroit, MI USA

来源：

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH | 2014年 / 40卷 / 05期

关键词：

review; squamous cell cancer; vulvar cancer; GYNECOLOGIC-ONCOLOGY-GROUP; LOCALLY ADVANCED-CARCINOMA; SEPARATE GROIN INCISIONS; LYMPH-NODE METASTASES; PHASE-II TRIAL; RADIATION-THERAPY; RADICAL VULVECTOMY; NEOADJUVANT CHEMOTHERAPY; INGUINAL LYMPHADENECTOMY; PROGNOSTIC-FACTORS;

D O I：

10.1111/jog.12352

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Squamous cell vulvar cancer is a rare gynecologic malignancy. Standard treatment for early stage disease consists of wide radical excision of the primary tumor with inguinal-femoral lymphadenectomy or sentinel lymph node mapping/biopsy. Because of the general paucity of patients with advanced vulvar cancer, there is no standard therapy for advanced disease and therefore treatment should be individualized. Intergroup trials are needed to clarify the value of chemoradiation, neoadjuvant chemotherapy and targeted therapy in patients with advanced squamous cell cancer of the vulva to identify modalities with the best therapeutic index and lowest morbidity.

引用

页码：1217 / 1225

页数：9